Valuation: West Pharmaceutical Services, Inc.

Market Cap 24B 20.85B 19.47B 17.87B 33.7B 2,287B 34.29B 230B 89.91B 1,141B 90.13B 88.13B 3,762B P/E 2026 *
39.8x
P/E 2027 * 34.6x
Enterprise Value 23.49B 20.42B 19.06B 17.5B 33B 2,239B 33.57B 225B 88.03B 1,117B 88.24B 86.29B 3,683B EV / Sales 2026 *
6.96x
EV / Sales 2027 * 6.4x
Free-Float
92.89%
Yield 2026 *
0.26%
Yield 2027 * 0.29%
1 day+0.71%
1 week-1.37%
1 month-6.97%
1 week 271.29
Extreme 271.288
273.98
1 month 271.29
Extreme 271.288
294.27
Current year 253.33
Extreme 253.329
294.27
1 year 253.33
Extreme 253.329
294.27
3 years 253.33
Extreme 253.329
294.27
5 years 253.33
Extreme 253.329
294.27
10 years 253.33
Extreme 253.329
294.27
Manager TitleAgeSince
Chief Executive Officer 56 24/04/2015
Director of Finance/CFO 57 04/08/2025
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Director/Board Member 65 01/02/2011
Director/Board Member 69 07/03/2011
Director/Board Member 56 12/02/2012
Change 5-day change 1-year change 3-year change Capi.($)
+0.71%-1.37% - - 24B
+1.39%+2.56%-17.52%-0.34% 183B
+1.52%+2.80%-3.41%+2.47% 109B
-0.58%-0.51%+5.42%+61.76% 60.57B
+2.37%+2.85%+44.34%+56.22% 51.8B
+2.55%+6.83%-5.10%-36.82% 45.64B
+3.48%+2.48% - - 33.22B
+4.30%+18.45%+13.98%-28.80% 31.49B
+1.95%+6.40%+1.73%+3.05% 22.26B
-0.54%+6.79%-9.83%+2.17% 21.51B
Average +1.72%+4.90%+3.70%+7.46% 62.08B
Weighted average by Cap. +1.59%+3.50%-1.75%+8.35%

Financials

2026 *2027 *
Net sales 3.37B 2.93B 2.74B 2.51B 4.74B 322B 4.82B 32.29B 12.64B 160B 12.68B 12.39B 529B 3.59B 3.12B 2.91B 2.67B 5.04B 342B 5.13B 34.32B 13.44B 171B 13.47B 13.18B 562B
Net income 615M 534M 499M 458M 863M 58.58B 878M 5.88B 2.3B 29.21B 2.31B 2.26B 96.35B 701M 609M 569M 522M 985M 66.84B 1B 6.71B 2.63B 33.33B 2.63B 2.58B 110B
Net Debt -503M -437M -408M -375M -707M -47.97B -719M -4.82B -1.89B -23.92B -1.89B -1.85B -78.9B -1.04B -903M -843M -774M -1.46B -99.04B -1.48B -9.94B -3.89B -49.39B -3.9B -3.82B -163B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - proprietary products (80.7%); - - contract-manufactured products (19.3%). At the end of 2024, the group had 21 production sites worldwide. Net sales are distributed geographically as follows: the United States (42.5%), Germany (12.9%), Ireland (11.2%), France (8.4%), Europe (13.3%) and other (11.7%).
Employees
10,800
Date Price Change
31/07/26 CHF 273.22 +0.71%
30/07/26 CHF 271.29 -0.98%
29/07/26 CHF 273.98 +0.11%
28/07/26 CHF 273.68 +0.79%
27/07/26 CHF 271.55 -1.97%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
340.96USD
Average target price
404.73USD
Spread / Average Target
+18.70%

Quarterly revenue - Rate of surprise